JNJ

173.89

+0.19%↑

ABBV

198.28

+0.11%↑

AZN

74.06

+0.64%↑

NVS

118.5

+1.46%↑

ABT

131.52

-2.16%↓

JNJ

173.89

+0.19%↑

ABBV

198.28

+0.11%↑

AZN

74.06

+0.64%↑

NVS

118.5

+1.46%↑

ABT

131.52

-2.16%↓

JNJ

173.89

+0.19%↑

ABBV

198.28

+0.11%↑

AZN

74.06

+0.64%↑

NVS

118.5

+1.46%↑

ABT

131.52

-2.16%↓

JNJ

173.89

+0.19%↑

ABBV

198.28

+0.11%↑

AZN

74.06

+0.64%↑

NVS

118.5

+1.46%↑

ABT

131.52

-2.16%↓

JNJ

173.89

+0.19%↑

ABBV

198.28

+0.11%↑

AZN

74.06

+0.64%↑

NVS

118.5

+1.46%↑

ABT

131.52

-2.16%↓

Search

Perrigo Co PLC

Suletud

SektorTervishoid

22.02 -2.78

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

21.76

Max

22.48

Põhinäitajad

By Trading Economics

Sissetulek

38M

-6.4M

Müük

-94M

1B

Dividenditootlus

4.22

Kasumimarginaal

-0.613

Töötajad

8,379

EBITDA

13M

127M

Soovitused

By TipRanks

Soovitused

Osta

12 kuu keskmine prognoos

+39.69% upside

Dividendid

By Dow Jones

Dividenditootlus

Sektori keskmine

4.22%

2.54%

Järgmine dividendimakse kuupäev

16. sept 2025

Järgmine aktsia dividendi kuupäev (ex-date)

29. aug 2025

Turustatistika

By TradingEconomics

Turukapital

352M

3.7B

Eelmine avamishind

24.8

Eelmine sulgemishind

22.02

Uudiste sentiment

By Acuity

12%

88%

11 / 374 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Strong Bullish Evidence

Perrigo Co PLC Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

14. juuli 2025, 13:01 UTC

Omandamised, ülevõtmised, äriostud

Perrigo to Sell Dermacosmetics Business to KKR With Focus on Streamlining Company

28. veebr 2025, 17:42 UTC

Suurimad hinnamuutused turgudel

Perrigo Shares Jump on FDA's Move to Reclassify Wisconsin Infant-Formula Plant

27. veebr 2025, 23:52 UTC

Tulu

Perrigo Gets Facility Reclassification From FDA as 4Q Profit, Revenue Fall

14. juuli 2025, 12:33 UTC

Omandamised, ülevõtmised, äriostud

Perrigo: Business Generated About 5% of 2024 Adjusted Operating Income >PRGO

14. juuli 2025, 12:33 UTC

Omandamised, ülevõtmised, äriostud

Perrigo: Dermacosmetics Branded Business Generated About EUR125 Million Sales in 2024 >PRGO

14. juuli 2025, 12:32 UTC

Omandamised, ülevõtmised, äriostud

Perrigo: Deal Proceeds to Further Strengthen Balance Sheet >PRGO

14. juuli 2025, 12:31 UTC

Omandamised, ülevõtmised, äriostud

Perrigo: Deal Includes EUR300 Million Upfront Cash, Up to EUR27 Million Contingent Payments >PRGO

14. juuli 2025, 12:31 UTC

Omandamised, ülevõtmised, äriostud

Perrigo To Sell Dermacosmetics Branded Business to KKR Investment Vehicle >PRGO

14. juuli 2025, 12:30 UTC

Omandamised, ülevõtmised, äriostud

Perrigo Announces Agreement to Divest Dermacosmetics Business for Up to EUR327 Million

Võrdlus sarnastega

Hinnamuutus

Perrigo Co PLC Prognoos

Hinnasiht

By TipRanks

39.69% tõus

12 kuu keskmine prognoos

Keskmine 31.5 USD  39.69%

Kõrge 40 USD

Madal 24 USD

Põhineb 4 Wall Streeti analüütiku instrumendi Perrigo Co PLC 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

4 ratings

2

Osta

2

Hoia

0

Müü

Tehniline skoor

By Trading Central

25.22 / 26.85Toetus ja vastupanu

Lühikene perspektiiv

Strong Bullish Evidence

Keskpikk perspektiiv

Strong Bullish Evidence

Pikk perspektiiv

Bullish Evidence

Sentiment

By Acuity

11 / 374 Pingereas Tervishoid

Uudiste sentiment

Väga tugevad tõusu märgid

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Alla keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Perrigo Co PLC

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. It also offers healthy lifestyle products, such as smoking cessation, well-being, and weight management products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women's health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; rare diseases business; and other miscellaneous self-care products. The company sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, Compeed Stops, XLS, Arterin, Davitamon, Apiserum, Abtei, and Nicorette brands. It also offers contract manufacturing services. The company sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.